Healthcare spending up 5.2% in June 2018 from previous year

National health spending rose 5.2 percent to $3.66 trillion in June 2018 from the previous year, according to a new insights report from Alarum.

June’s health spending accounted for 17.9 percent of U.S. GDP, which grew 4.9 percent over the 12-month period. Healthcare spending is expected to reach 20 percent of GDP over the next several years. For the first six months of 2018, national health spending rose 4.9 percent, year over year.

Altarum is a nonprofit health systems research and consulting firm based in Ann Arbor, Michigan.

The spending increase is on par with the past couple years, with spending steadily trending up since the start of the recession. From December 2007 through June 2018, real health spending has increase 31.4 percent. Real GDP without healthcare, by comparison, is up 14.4 percent from is December 2007 low. With healthcare included, GDP in June 2018 was 17.1 percent above its pre-recession level, according to Altarum.

Overall, annualized national health spending for the first five months of 2018 was slightly higher than originally estimated, at 0.67 percent. Hospital care, which represents 32 percent of national health spending, is largely responsible for the uptick. Hospital care is 2.04 percent higher, year to date, than previously estimate, reaching $1.17 trillion.

Behind hospital care, physician and clinical services make up 20 percent of healthcare spending, at $733 billion. Prescription drugs made up 10 percent of spending, at $355 billion, while nursing home care was 5 percent, dental services was 4 percent and home healthcare was 3 percent. Personal healthcare goods and services accounted for 85 percent of total health spending. The remaining 15 percent included public health, research, construction and net cost of private insurance.

Over the 12-month period, dental services grew the most rapidly among all major care categories, by 7.7 percent. Dental services overtook home health care as the leader in growth, as it jumped 5.9 percent in spending for the preceding 12-month period ending June 2017. Prescription drug expenditures grew just 3 percent as of June 2018 from the previous year.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.